Olmesartan Medoxomil E Idroclorotiazide Mylan (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil E Idroclorotiazide Mylan, is an antihypertensive presented as a tablet for oral use. It treats high blood pressure, often in combination with other agents, and is used in adults. GNH USA supplies Olmesartan Medoxomil E Idroclorotiazide Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomil E Idroclorotiazide Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxomil combined with hydrochlorothiazide is indicated for management of hypertension, particularly in patients who require additional blood pressure reduction beyond monotherapy.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Resistant hypertension: provides added diuretic effect to achieve target pressures when ARB alone is insufficient. - Hypertension with fluid retention: combines vasodilation with diuresis to improve overall blood pressure control.

Olmesartan medoxomil with hydrochlorothiazide is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Increased urination - Electrolyte disturbances (e.g., low potassium) - Mild gastrointestinal upset

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Hyperkalemia or severe electrolyte imbalance - Angio‑edema involving the face, lips or tongue - Liver function abnormalities - Blood dyscrasias such as agranulocytosis

When prescribing Olmesartan Medoxomil E Idroclorotiazide Mylan, clinicians should consider several safety aspects.

- Renal function: assess baseline kidney function and monitor periodically. - Electrolyte balance: check serum potassium and sodium levels, especially in patients on other diuretics. - Pregnancy: avoid use during pregnancy due to risk of fetal toxicity. - Concomitant drugs: review for potential interactions that may affect blood pressure or renal function. - Elderly patients: start at lower doses and monitor for orthostatic hypotension. Store at ambient: keep 

-  

Olmesartan medoxomil  

g